flag peptide has been researched along with Cancer of Prostate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bettuzzi, S; Paciucci, R; Santamaria, A; Scaltriti, M | 1 |
Amorino, GP; Casarez, EV; Cox, ME; Davidson, RJ; Deeble, PD; Frierson, HF; Palmer, JB; Parsons, SJ; Sikes, RA | 1 |
2 other study(ies) available for flag peptide and Cancer of Prostate
Article | Year |
---|---|
Intracellular clusterin induces G2-M phase arrest and cell death in PC-3 prostate cancer cells1.
Topics: Amino Acid Sequence; Apoptosis; Base Sequence; Cell Cycle; Cell Division; Cell Line, Tumor; Clusterin; G2 Phase; Genetic Vectors; Glycoproteins; Humans; Male; Mitosis; Molecular Chaperones; Molecular Sequence Data; Oligopeptides; Peptides; Prostatic Neoplasms; Protein Isoforms; Subcellular Fractions; Transfection | 2004 |
Androgen-independent growth and tumorigenesis of prostate cancer cells are enhanced by the presence of PKA-differentiated neuroendocrine cells.
Topics: Animals; Catalytic Domain; Cell Adhesion; Cell Differentiation; Cell Growth Processes; Cell Line, Tumor; Cyclic AMP-Dependent Protein Kinases; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mitosis; Neoplasms, Hormone-Dependent; Neuroendocrine Tumors; Oligopeptides; Peptides; Prostate-Specific Antigen; Prostatic Neoplasms | 2007 |